Heru Series A Funding Accelerates Cloud and Artificial Intelligence-Enabled Wearable Vision Diagnosis and Therapy
– Heru Inc. closed its Series A financing of $30m to advance the company’s eye diagnostic and vision correction technology platform.
– The Series A funding round was led by global investment firm D1 Capital Partners with participation from SoftBank Ventures Opportunity Fund, Maurice R. Ferre, M.D., Frederic H. Moll, M.D., Krillion Ventures, and a consortium of investors with extensive experience developing, launching and scaling cutting-edge medical technologies.
– Originating as a spinout from Bascom Palmer Eye Institute, the Series A follows FDA registration and a $2.7m seed round announced in December 2020.
– An estimated 450m people worldwide experience visual field defects or double vision, but limited access can mean long waits for eye appointments.